# CJNV BioVentures

> CJNV BioVentures is a VC fund backing Biotechnology, Health Care and Oncology. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 3
- Last investment: Jan 2024
- Lead investor: 0%
- Last updated: Aug 2026

CJNV BioVentures is a venture capital firm

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 100% |
| Health Care | 2 | 67% |
| Oncology | 1 | 33% |
| Life Science | 1 | 33% |
| Therapeutics | 1 | 33% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 67% |
| Seed | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| OnCusp Therapeutics | OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.It is always working to improve the largest value inflection point in the drug development value chain, believing that speeding oncology medication innovation is the most effective method to provide help and hope to cancerpatients around the world.It is founded by Bing Yuan, Eric Slosberg, and Andy Fu. | $100M | Series A | Jan 04, 2024 |  |
| Noetik | Noetik is an AI-native biotechnology company. Noetik leverages in advanced machine learning methods to discover and develop cancer immunotherapies. | $14M | Seed | Sep 07, 2023 |  |
| Georgiamune | Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases. | $75M | Series A | Aug 09, 2023 |  |

3 of 3 investments shown.

## Co-investors
- [Catalio Capital Management](https://shizune.co/investors/profile/catalio-capital-management) — VC Fund, 3 deals together
- [BioTrack Capital](https://shizune.co/investors/profile/biotrack-capital) — VC Fund, 2 deals together
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund, 2 deals together
- Parker Institute for Cancer Immunotherapy — VC Fund, 2 deals together
- [11.2 Capital](https://shizune.co/investors/profile/112capital) — VC Fund, 1 deal together
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does CJNV BioVentures invest in?

CJNV BioVentures invests primarily in Biotechnology, Health Care and Oncology startups, most often at Series A and Seed stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did CJNV BioVentures last invest?

The most recent investment recorded for CJNV BioVentures closed in Jan 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co